Open Access

Elimination of Aspergillus fumigatus conidia from the airways of mice with allergic airway inflammation

  • Marina A Shevchenko1Email author,
  • Elena L Bolkhovitina1,
  • Ekaterina A Servuli1, 2 and
  • Alexander M Sapozhnikov1
Respiratory Research201314:78

https://doi.org/10.1186/1465-9921-14-78

Received: 14 March 2013

Accepted: 23 July 2013

Published: 27 July 2013

Abstract

Background

Aspergillus fumigatus conidia can exacerbate asthma symptoms. Phagocytosis of conidia is a principal component of the host antifungal defense. We investigated whether allergic airway inflammation (AAI) affects the ability of phagocytic cells in the airways to internalize the resting fungal spores.

Methods

Using BALB/c mice with experimentally induced AAI, we tested the ability of neutrophils, macrophages, and dendritic cells to internalize A. fumigatus conidia at various anatomical locations. We used light microscopy and differential cell and conidium counts to determine the ingestion potential of neutrophils and macrophages present in bronchoalveolar lavage (BAL). To identify phagocyte-conidia interactions in conducting airways, conidia labeled with tetramethylrhodamine-(5-(and-6))-isothiocyanate were administered to the oropharyngeal cavity of mice. Confocal microscopy was used to quantify the ingestion potential of Ly-6G+ neutrophils and MHC II+ antigen-presenting cells located in the intraepithelial and subepithelial areas of conducting airways.

Results

Allergen challenge induced transient neutrophil recruitment to the airways. Application of A. fumigatus conidia at the acute phase of AAI provoked recurrent neutrophil infiltration, and consequently increased the number and the ingestion potential of the airway neutrophils. In the absence of recurrent allergen or conidia provocation, both the ingestion potential and the number of BAL neutrophils decreased. As a result, conidia were primarily internalized by alveolar macrophages in both AAI and control mice at 24 hours post-inhalation. Transient influx of neutrophils to conducting airways shortly after conidial application was observed in mice with AAI. In addition, the ingestion potential of conducting airway neutrophils in mice with induced asthma exceeded that of control mice. Although the number of neutrophils subsequently decreased, the ingestion capacity remained elevated in AAI mice, even at 24 hours post-conidia application.

Conclusions

Aspiration of allergen to sensitized mice enhanced the ingestion potential of conducting airway neutrophils. Such activation primes neutrophils so that they are sufficient to control dissemination of non-germinating A. fumigatus conidia. At the same time, it can be a reason for the development of sensitivity to fungi and subsequent asthma exacerbation.

Keywords

Allergic airway inflammation Aspergillus fumigatus NeutrophilsMucosal dendritic cellsConducting airwayConfocal laser scanning microscopy

Background

Aspergillus are among the most common airborne fungi [1]. Fungal spores are present in both outdoor and indoor air, primarily in a resting or dormant state [2]. The inhalation of Aspergillus conidia can induce allergic sensitization and exacerbate the allergic airway inflammation (AAI) [3, 4]. Moreover, cardinal features of allergic asthma, such as IL-13-mediated mucus production and goblet cell hyperplasia, are important for fungal clearance and antifungal host defense [5, 6]. Despite the allergic potential of fungi, only 13% of asthmatic patients show sensitization to Aspergillus species [7]. The low sensitivity can be partially explained by the resting or dormant state of the inhaled conidia [2, 8]. A hydrophobic surface layer covers resting conidia and masks the fungal molecular patterns, thereby protecting conidia from immune system recognition [8, 9]. Such inertness allows a tolerance to airborne fungi by immunocompetent hosts [10].

Although resting A. fumigatus conidia do not activate the immune system [8, 11], they can enhance pre-existing AAI. Thus, inactivated A. fumigatus spores trigger Th2 cytokine production by CD4+ T-cells that have been previously stimulated with antigen-pulsed antigen-presenting cells (APCs) [12]. Fukushima et al. [4] injected mice exhibiting mite-induced AAI with heat inactivated conidia, which mimic the resting fungal spores, and observed increased bronchoalveolar lavage (BAL) eosinophil number, as well as IL-5 and IL-13 expression by the lung cells. Hence, daily exposure to ubiquitous dormant A. fumigatus conidia induces tolerance in healthy people, but can provoke exacerbation in asthmatics.

Neutrophils are the predominant inflammatory cells that infiltrate airways during acute exacerbation of asthma [13]. Neutrophils also play an essential role in antifungal defense [14, 15]. They rapidly migrate to the infected lungs and suppress conidial germination through phagocytosis or extracellular trap formation [16, 17]. Allergen challenge also induces transient neutrophil recruitment to the airways [18, 19]. However, neutrophils from the sputum of asthmatics produce lower levels of IL-8, IL-1β, and TNF-α, and show reduced levels of TLR4 mRNA expression [20]. Therefore, the alteration of neutrophil functions in asthma can be a trigger for tolerance-to-sensitivity shift.

To determine whether allergic asthma alters the ingestion activity of phagocytic airway cells, we examined the ability of neutrophils, macrophages, and dendritic cells (DCs) to control resting A. fumigatus conidial dissemination in the airways of mice with AAI. To accomplish this, mice with ovalbumin (OVA)-induced AAI were inoculated via inhalation with fixed A. fumigatus conidia at the acute stage of inflammation. Analysis of the phagocytic cells and conidial interactions at different time points, and in various anatomical compartments of the respiratory tract, enabled us to identify the elevated ingestion potential of conducting airway neutrophils as a sustained attribute of AAI, independent from the recruited neutrophil number.

Methods

Animals

Eight-week-old BALB/c mice (Charles River Laboratories, Sulzfeld, Germany, and the Central Laboratory of the Animal Breeding Facility, Russian Academy of Medical Sciences, Moscow, Russia) were used in the study. Animals were fed with OVA-free laboratory food and tap water ad libitum, and held in regular 12-hour dark:light cycles at 22°C. Animal experiments were performed in concordance with the German animal protection law, under a protocol approved by the appropriate governmental authority (Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit), or in accordance with the Guide for the Care and Use of Laboratory Animals, under a protocol approved by the Institutional Animal Care and Use Committee of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS.

A. fumigatusstrain, media, and growth conditions

A. fumigatus clinical isolate D141 [21] was used in the present study. The fungus was grown at 37°C on Aspergillus minimal medium (AMM) containing 1% D-glucose as the carbon source and 70 mM NaNO3 as the nitrogen source. A fungal suspension was transferred to AMM agar plates and incubated for 3 days at 37°C. Harvested conidia were fixed overnight with 3% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA), washed twice with PBS, and then labeled with tetramethylrhodamine-(5-(and-6))-isothiocyanate (TRITC) (Molecular Probes, Eugene, Oregon, USA) according to the manufacturer's instructions. TRITC-labeled spores were filtered through Steriflip Filter Units (Millipore, Cork, Ireland), aliquoted, and stored at 4°C until use. Viability tests were performed by inoculating an aliquot of stained conidia onto an AMM agar plate and incubating for 3 days at 37°C.

Induction of AAI

BALB/c mice were sensitized with 10 μg OVA Grade VI (Sigma-Aldrich) adsorbed to 1.5 mg of Imject alum (Thermo Scientific, Rockford, IL, USA) diluted in PBS. OVA inoculation was carried out on days 0, 14, and 21 via intraperitoneal (i.p.) injection. The animals were then challenged with 1% OVA aerosol in PBS for 20 minutes on day 27 (OVA/OVA). The negative control groups (OVA/PBS) were exposed to PBS instead of OVA aerosol.

Application of A. fumigatusconidia

At the acute stage of AAI, 12 hours after single OVA aerosol challenge, mice received 5 × 106 TRITC-labeled A. fumigatus conidia/mouse (n = 3–5 per group per time point). Mice were anesthetized with 2-bromo-2-chloro-1,1,1-trifluoroethane (Sigma-Aldrich). Conidia were dissolved in PBS to a concentration of 1 × 108 conidia/mL and administrated to the oropharyngeal cavity of mice [22] in a total volume of 50 μL. Then mice were subjected to either BAL collection or whole-mount airway dissection.

BAL collection

Animals were lethally anesthetized with an overdose of i.p.-administered pentobarbital (Narcoren; Rhone Merieux, Laupheim, Germany) immediately before A. fumigatus conidia application (0 hours), and at 2, 4, 8, and 24 hours post-application of conidia. BAL was performed twice with 0.8 mL of ice-cold sterile PBS. Cells were quantified using a Goryaev-chamber (Minimed, Suponevo, Bryansk, Russia), and diluted to a concentration of 1 × 106 cells/mL. Cells were then transferred onto glass slides using a Cytospin 2 centrifuge (Shandon, London, UK). Cells were stained using a Diff-Quik stain set (Diachem, Saint-Petersburg, Russia), and the differential cell counts were assessed. Conidia that were internalized by BAL phagocytic cells and non internalized conidia were counted.

Tissue processing and whole-mount immunostaining

The tissue was processed as described earlier [23]. Briefly, animals were lethally anesthetized as described above; the lungs were inflation-fixed with 2% paraformaldehyde (Sigma-Aldrich), and the main axial pathways of each lobe were microdissected. The airways were then washed with PBS for 1 hour and permeabilized with 0.3% Triton X-100 in PBS for 2 hours. Washings with PBS (3 times for 10 minutes) accompanied each step of the staining. Bronchi were then blocked with 1% BSA in PBS and immunostained as whole-mounts. The left lung and the right inferior lobe were used for specific antibody staining analysis, and the right middle and post-caval lobes were used for isotype controls (Additional file 1: Figure S1). All antibodies were diluted in PBS supplemented with 0.5% BSA and 4% mouse, rat, or donkey serum according to the antibody type. Directly FITC-conjugated rat monoclonal anti-mouse Ly-6G antibody (clone RB6-8C5; eBioscience, San Diego, CA, USA) and primary rat anti-mouse I-A/I-E antibody (clone M5/114.15.2; Biolegend, San Diego, CA, USA) were used at a dilution of 1/50. The Cy5-conjugated donkey anti-rat IgG secondary antibody (Jackson Immuno Research, West Grove, PA, USA) was used at a dilution of 1/400. Finally, all samples were mounted in Prolong Gold mounting medium (Molecular Probes, Eugene, OR, USA).

Confocal microscopy

Images were acquired using an LSM 510 META (Carl Zeiss, Jena, Germany) confocal microscope using 20× and 40× (water immersion) objectives. Laser wavelengths of 488 nm, 543 nm, and 633 nm were used for the excitation of the fluorochromes FITC, TRITC, and Cy-5, respectively. Specimens were scanned in Z-stack "channel/multi-tracking" mode with the appropriate emission filters. For quantitative analysis, the image stacks containing the airway epithelium and smooth muscle layer were scanned with an XYZ-resolution of 1024 × 1024 × 70, with dimensions of 318.2 μm × 318.2 μm × 39.81 μm, respectively. Airways were divided into four segments: two proximal (dorsal and ventral), and two distal (dorsal and ventral). At least two image stacks were taken at each segment, one on the ventral and one on the dorsal side of the main axial pathway. Preference was given to locations containing a minimum of one A. fumigatus conidium. Confocal images were shown as two-dimensional maximum intensity projections (MIPs) or three-dimensional surface objects. The final image processing was carried out using Adobe Photoshop CS version 5 software (Adobe Systems, Mountain View, CA, USA).

Quantitative image analysis

Image stacks were analyzed using Imaris 6.2.1 software developed by Bitplane (Zurich, Switzerland). Surface rendering was performed using optimal threshold settings in the Ly-6G (neutrophils), A. fumigatus conidia, and MHC II (APC) channels by "region growing" [23]. Threshold and filter settings were optimized by visually comparing the result with the MIP. Cell numbers were automatically calculated from the respective surface objects. To quantify the number of conidia taken up by neutrophils and APCs, in the A. fumigatus conidia channel the mean intensity filter was adjusted for the Ly-6G+ and MHC II+ channels, respectively. To identify Ly-6G+ and MHC II+ cells that had internalized conidia, cells with a mean fluorescence intensity above a certain threshold in the A. fumigatus conidia channels were selected. Visual control of selection regions was carried out.

Statistical analysis

Data are expressed as mean ± SEM. To compare groups of mice, and airway segments 2-way ANOVA test and Bonferroni post-test were applied. Cell and conidia numbers or ratios between the indicated time point and the initial time point were compared using one-way ANOVA and Dunnett's multiple comparison tests. Tests were performed using GraphPad Prism version 4.03 for Windows (GraphPad Software, San Diego, CA, USA). Differences with p < 0.05 were considered statistically significant.

Results

Contribution of different BAL phagocytic cells to A. fumigatusconidial internalization in mice with AAI

In the present study, we used a well-established OVA-induced mouse model of AAI. Mice were inoculated with A. fumigatus conidia via inhalation at the acute phase of AAI, 12 hours post-single allergen challenge (Figure 1A). To mimic the resting state of conidia, and to exclude an activation of the immune system as a result of conidial germination, freshly harvested conidia were fixed with paraformaldehyde. The control inoculation revealed the absence of conidial growth within 72 hours of incubation at 37°C.
Figure 1

Internalization of A. fumigatus conidia by BAL cells during AAI. (A) Mice received three i.p. injections of OVA (on days 0, 7, and 21; 10 μg/mouse/injection), and were challenged on day 27 with OVA (1% in PBS) (OVA/OVA group) or PBS (OVA/PBS group). Mice were inoculated with A. fumigatus conidia via inhalation at 24 hours post-allergen challenge. BAL samples were analyzed at 0, 2, 4, and 24 hours post-conidial administration. (B) Total and differential cell numbers immediately before conidia application were evaluated. NM – non-treated mice. (C) The neutrophil to macrophage ratio in BALs of OVA/PBS (open bars) or OVA/OVA (black bars) mice at the indicated time points following conidial application. (D) The ratio of internalized by neutrophils to internalized by macrophages conidia numbers at the different time points following conidial application to OVA/PBS (open bars) and OVA/OVA (black bars) mice. Data are shown as means ± SEM for two representative experiments, with three and five mice per group. OVA/OVA versus OVA/PBS group or OVA/PBS versus NM: * (p < 0.05), *** (p < 0.001), and ns: not significant. Neutrophil to macrophage ratio at the indicated time point versus the time point immediately before conidial application: § (p < 0.01).

The total leukocyte recruitments and differential BAL cell compositions were compared for OVA/PBS, OVA/OVA, and intact mice 12 hours following the allergen inhalation immediately before conidia application. Both total cell number and the number of macrophages, neutrophils, eosinophils, and lymphocytes elevated significantly in the BAL of mice with acute phase AAI (Figure 1B).

The numbers of macrophages, neutrophils, eosinophils, lymphocytes, and A. fumigatus conidia in the BALs of mice were quantified at 2, 4, and 24 hours post-application of conidia. We used the ratios of neutrophils to macrophages to identify the prevalence of the respective phagocytes at different time points. Instilled conidia induced neutrophil recruitment in both OVA/PBS and OVA/OVA mice (Figure 1C, Additional file 2: Figure S2A,B), but only in OVA/OVA group neutrophils outnumbered macrophages (Figure 1C). The percentage of conidia internalized by BAL phagocytes referred to hereafter as the ingestion potential of the phagocytes, and the ratios of neutrophil ingestion potentials to these of macrophages indicated the dominance of neutrophils or macrophages in conidia internalization at the different time points. We observed the correlation between the number and ingestion potential of BAL neutrophils in mice with AAI. Thus, at 4 hours after conidial application, the ingestion potential of neutrophils significantly exceeded that of alveolar macrophages in OVA/OVA animals (Figure 1D, Additional file 2: Figure S2D) but not in OVA/PBS mice (Figure 1D, Additional file 2: Figure S2C). At 24 hours post-inhalation of conidia, both the percentage (Figure 1C) and the ingestion potential (Figure 1D) of BAL neutrophils decreased, and macrophages became the cells predominantly responsible for conidial internalization in both OVA/PBS and OVA/OVA mice (Figure 1C,D, Additional file 2: Figure S2C,D). These results demonstrated that within 24 hours, BAL phagocytic cells internalized more than 80% of aspirated A. fumigatus conidia. Consequently, the majority of conidia was captured, and therefore could not penetrate the epithelial barrier and disseminate into the airway tissues.

Visualization of A. fumigatus conidia, neutrophils, and MHC II+APCs in the conducting airway mucosa

Upon inhalation, A. fumigatus conidia were disseminated throughout the conducting airways and penetrated the small airways [17]. The airway mucosa is the primary site of interactions between conidia and host immune cells; therefore, we focused on precise analysis of the conducting airway mucosa. To detect the location of conidia along the length of the intrapulmonary (bronchial) conducting airway, we administrated TRITC-labeled conidia to the pharyngeal cavity of mice. Confocal images of whole-mounted conducting airways enabled us to identify the distribution of conidia at the proximal and distal segments of the conducting airways (Figure 2A). High-resolution confocal image stacks served as a basis for the generation of three-dimensional surface objects, which were used to detect single conidia both in the epithelial compartment and subepithelial area of the airway mucosa. We identified conidia as globular objects with an approximate diameter of 3 μm (Figure 2B,C). Quantitative analysis of the surface object distribution showed no preferential localization of conidia at any specific anatomical location; TRITC-labeled spores were scattered along the airway and distributed randomly within both proximal and distal airway segments (Additional file 3: Figure S3).
Figure 2

Distribution of A. fumigatus conidia and Ly-6G + neutrophils along the mouse conducting airway. The conducting airway was dissected from the right inferior lung lobe of intact mice that received 5 × 106A. fumigatus conidia 4 hours prior to dissection. (A) Microdissected mouse airway represented as montage of the number of confocal images scanned with low magnification from the luminal side of the specimen was arbitrarily separated (dashed lines) into proximal, distal, dorsal, and ventral regions. (B) Representative three-dimensional image showing the distribution of Ly-6G+ neutrophils (green) and TRITC-labeled A. fumigatus conidia (red) in the conducting airway mucosa. (C) The single conidium and (D) neutrophil indicated in (B) are represented as the three-dimensional objects. (E) The conidium located on the luminal side of the conducting airway epithelium, (F) in the subepithelial area, and (G) parenchymal tissue, is indicated by arrows on Z-projections (top view: E, F, G upper panels) and Y-projections (front view: E, F, G lower panels). Epithelial and subepithelial compartments were separated based on epithelium auto-fluorescence (dashed line on E, F, G lower panels). Scale bar = 20 μm (B, E, F, G); scale bar and greed spacing = 1 μm (C), and 5 μm (D).

Neutrophils were identified in conducting airways using anti Ly-6G staining. Ly-6G (also known as Gr-1 antigen) is a GPI-linked myeloid differentiation marker that is located on the outer side of the cell plasma membrane. Gr-1 is also expressed on plasmacytoid DCs, but this population is poorly represented in the mouse conducting airways [24, 25]. The three-dimensional surface rendering of the high resolution confocal images revealed a specific surface contour (spheroid object with several cavities) of Ly-6G positive cells (Figure 2B,D).

Conidia administrated to intact mice were detected not only on the luminal side of the epithelium (Figure 2E, red), but also beneath the epithelium (Figure 2F, red), and even in the lung tissue (Figure 2G, red). Neutrophils from control mice generally did not penetrate the epithelial barrier, and occupied the subepithelial compartment and parenchymal tissue (Figure 2E-G, green).

To identify conducting airway APCs, which can also take part in internalization of conidia, we used anti-MHC II staining. Using the findings of Veres et al. [26], we identified two populations of conducting airway mucosal MHC II+ APCs, which were distinguished by the morphology and anatomical location: an epithelial (or intraepithelial) DC population, and a population containing subepithelial DCs (Additional file 4: Figure S4A,D,G and C,F,I: epithelial DCs, arrows; subepithelial DCs, arrowheads). Although several studies using flow cytometry of peripheral blood and lymph node leukocyte samples have reported that neutrophils are capable of expressing MHC class II [27], we did not identify expression of MHC II molecules on the surface of Ly-6G+-conducting airway neutrophils by confocal microscopy of the main bronchus specimen (Additional file 4: Figure S4B,E,H,C,F,I: MHC II, yellow; Ly6-G, green).

Distribution of neutrophils recruited to conducting airway mucosa of mice with AAI in response to A. fumigatusconidia application

To investigate the difference in antifungal neutrophil activity between AAI and control mice at 24 hours post-challenge, both groups were inoculated with A. fumigatus conidia via inhalation. We compared the spatial location of neutrophils in the conducting airways of OVA/OVA and OVA/PBS mice shortly after conidial application.

The results demonstrated that in the absence of preexisting AAI, Ly-6G+ neutrophils located strongly in the subepithelial compartment of the conducting airway mucosa (Figure 3A). In contrast to the OVA/PBS group, neutrophils from OVA/OVA mice were detected in close proximity to the epithelium (Figure 3B), as well as in the epithelial compartment of the airway mucosa (Figure 3B; arrow).
Figure 3

A. fumigatus conidia-induced recruitment of neutrophils to the conducting airways of mice with AAI. Representative confocal images taken from the distal ventral segment of conducting airway at 2 hours post-conidial inhalation by (A) OVA/PBS and (B) OVA/OVA mice. Images are represented as Z- (upper panels) and Y-projection (lower panels). Ly-6G+ neutrophils are shown in green and epithelial auto-fluorescence in dark green. Epithelial and subepithelial compartments, separated by a dashed line, were determined based on epithelial auto-fluorescence (lower panels). Neutrophil in the epithelial compartment of the conducting airway mucosa is indicated by arrow. The images are shown as MIP and the scale bar = 50 μm.

Internalization of A. fumigatusconidia by conducting airway phagocytic cells

We then analyzed the contribution of Ly-6G+ neutrophils and MHC II+ APCs to internalization of A. fumigatus conidia. In response to the allergen and conidial inhalation, neutrophils trafficked to the subepithelial and intraepithelial areas of conducting airways, and migrated through the epithelium. These neutrophils were predominantly observed in close proximity to the luminal side of the airway epithelium (Figure 4A: upper right; B: arrowhead). Neutrophils became activated following transepithelial migration and internalized conidia, thereby preventing contacts between the epithelial DCs and conidia (Figure 4A-D). Epithelial DC extensions were commonly observed to be projected toward A. fumigatus conidia; however, precise analyses of epithelial DC-neutrophil-conidia interactions revealed the absence of direct contact between epithelial DCs and neutrophils or conidia (Figure 4D).
Figure 4

Internalization of A. fumigatus conidia in the epithelial compartment of conducting airways. (A) Representative confocal image taken from the proximal ventral segment of the whole-mount airway main axial pathway showing the distribution of MHC II+ epithelial DCs (upper left panel: MHC II+ DCs, yellow; epithelium auto-fluorescence, dark yellow), Ly-6G+ neutrophils (upper right panel, green), A. fumigatus conidia (lower left panel, red), and a merged image (lower right panel) at 4 hours post-conidial application. Scale bar = 20 μm. (B, C) The neutrophil locating in close proximity to the luminal side of the epithelium (arrowhead) and the intraepithelial DC (arrow) are indicated on Z-projection (left panels) or on X-projection (right panels) of the area displayed in (A). (D) The same neutrophil and DC are displayed on the three-dimensional larger magnification image of the region boxed in (A). Scale bar = 20 μm (A, B, C); and 10 μm (D).

We observed the internalization of conidia by epithelial DCs is just three out of more than 200 analyzed samples (Figure 5A-D). All examples of immediate interaction between MHC II+ cells possessing long cellular extensions and conidia were detected in OVA/PBS mice at 8 hours post-application of conidia. These interactions we not observed in OVA/OVA animals.
Figure 5

Capture of conidia by the conducting airway epithelial DCs. (A) Three-dimensional reconstitution of the image stacks taken from the proximal ventral region of the conducting airway showing the distribution of Ly-6G+ neutrophils (bright green), epithelium auto-fluorescence (dark green), MHC II+ APCs (yellow), and A. fumigatus conidia (red) in an OVA/PBS mouse at 8 hours post-conidial application. Scale bar = 50 μm. (B) Three-dimensional reconstitution of the area indicated on (A) representing MHC II+ APCs (yellow) and A. fumigatus conidia (red: arrow); scale bar = 10 μm. (C) X, Y, and Z-projections of the area framed in (A) showing the precise location of an intraepithelial (epithelium auto-fluorescence, green) and epithelial DC (yellow) that internalized A. fumigatus conidia (red: arrow). Scale bar = 20 μm. (D) An epithelial DC that internalized conidia is represented as the enlarged and arbitrary rotated three-dimensional surface object. Scale bar = 5 μm.

We visualized free conidia and conidia captured by phagocytic cells in the subepithelial area of the conducting airway. Both neutrophils and subepithelial DCs took part in conidial internalization (Additional file 5: Figure S5A,B).

Quantitative analyses of conidial internalization by the conducting airway neutrophils and APCs

To estimate the contribution of the different types of conducting airway phagocytic cells to dormant A. fumigatus conidial internalization, the number of ingested conidia and the ingestion rate were quantified for Ly-6G+ neutrophils and MHC II+ APCs.

As the total number of conidia (internalized by the phagocytes and non-internalized) in the conducting airways of both OVA/OVA and OVA/PBS mice did not vary significantly within 24 hours post-application (Additional file 6: Figure S6A), the percentage of conidia internalized by neutrophils or APCs reflected their ingestion effectiveness.

The transient influx of neutrophils to the subepithelial area of conducting airways was observed in mice with AAI at 2 hours post-application of A. fumigatus conidia (Figure 6A). At 4 hours post-application the number of Ly-6G+ cells in the OVA/OVA group decreased, and reached a level similar to that in control mice (Figure 6A). At 24 hours post-application, the number of neutrophils in the conducting airways of OVA/OVA mice was significantly lower than that in the OVA/PBS group (Figure 6A). However, this significant reduction in neutrophil number did not reflect the ability of neutrophils to uptake the conidia (Figure 6C, Additional file 6: Figure S6B,D). Although the cell number subsequently decreased, the ingestion potential of neutrophils in OVA/OVA mice increased, and significantly exceeded that of the respective control group at all time points following conidial inhalation (Figure 6C, Additional file 6: Figure S6F).
Figure 6

Quantitative analysis of the number and ingestion effectiveness of conducting airway neutrophils and APCs. The numbers of conducting airway Ly-6G+ neutrophils (A) and MHC II+ APCs per mm2 of epithelium (B) and the percentages of conidia that were internalized by neutrophils (C) and APCs from the total number of conidia in the region under observation (D) were detected. Data were acquired for OVA/OVA (black bars) or OVA/PBS (open bars) animals at different time points following A. fumigatus conidial application. Mean and SEM are presented for two independent experiments with three and four mice per group, respectively. The difference between OVA/OVA and OVA/PBS groups: ** (p< 0.01), *** (p< 0.001), and ns: not significant. Significant difference between neutrophil numbers and conidia percentages at initial and indicated time points: § (p<0.01).

Inhalation of conidia did not affect the total population of conducting airway DCs in either the OVA/OVA or OVA/PBS mice. There were no cardinal alterations in the total number (Figure 6B) and ingestion potential (Figure 6D, Additional file 6: Figure S6C,E,G) of conducting airway MHC II+ APCs at any of the analyzed time points.

Discussion

This study investigated how exposure to respiratory allergens affects the ability of phagocytic cells to control the dissemination of routinely inhaled corpuscular antigens, particularly resting A. fumigatus conidia, in the airway. We observed that allergen inhalation induced transient neutrophil recruitment at the acute phase of AAI, and that conidia introduced during the acute phase induced recurrent neutrophil infiltration. Neutrophils were primarily responsible for the internalization of the dormant fungal spores in both BAL and conducting of mice with AAI. In the absence of pathogen inhalation or repetitive airborne allergen exposure, neutrophil recruitment to the airway, along with their ingestion activity, was terminated. Therefore, the ingestion potential of BAL macrophages significantly increased at 24 hours post-application of conidia. While we observed a correlation between the number and ingestion capacity of BAL neutrophils, conducting airway neutrophils of AAI mice showed an enhanced ability to internalize conidia even though the neutrophil number decreased.

Neutrophils are not considered to be a major factor in AAI. However, increased numbers of airway neutrophils have been observed in both human and animal studies of allergic asthma [18, 19, 28, 29]. Consistent with these previous findings, we showed that a single exposure to an allergen (OVA) induces massive neutrophil infiltration to the airways shortly after allergen challenge. Such transient neutrophil influx is likely to be induced by allergen-specific antibodies or contamination of allergen with endotoxin [3032].

Neutrophils are the most important cells in early antifungal defense [14, 17]. In our model, the application of A. fumigatus conidia at the acute phase of AAI provoked de novo transient neutrophil recruitment, although the number of neutrophils in the airways was still increased. Because neutrophils migrate through the subepithelial area of conducting airways to reach the airway lumen, we observed simultaneous increases in neutrophil numbers in the BAL and conducting airways of mice in response to both allergen and conidial inhalation. However, we observed an earlier decrease in neutrophil numbers in conducting airways, which was followed later by a similar decrease in the BAL samples. Our observation confirms the one-way transepithelial traffic of neutrophils that was suggested previously [33]. Thus, in the absence of recurrent inhalation of exogenous irritants, the neutrophilic inflammation was resolved, as is the ability of BAL neutrophils to internalize dormant fungal spores. Notably, in BALs that were taken from mice 24 hours after conidial application, macrophages showed a greater contribution to conidial internalization than neutrophils, which highlights the major role of macrophages in the resolution of inflammation.

Because of their small size (3 μm), A. fumigatus conidia can penetrate the small airways and reach the alveoli [34, 35]. Therefore, the primary cells encountering the conidia were assumed to be alveolar macrophages [36]. However, Krenke et al. [37] observed that the tracheobronchial manifestations of Aspergillus infections could suggest that immune cells can sense conidia before they reach the alveoli. In the present study, we used three-dimensional mapping to investigate conidial distribution in conducting airway mucosa. We found that instilled conidia penetrated the airway epithelial border, and were present both on the luminal side of the bronchial epithelium and in the subepithelial area of conducting airways shortly after the inhalation. As alveolar macrophages do not reside at the luminal side of the bronchial epithelium, other immune cells must be responsible for fungal spore recognition and neutralization in the conducting airway compartment. Because of the specific location of airway mucosal DCs, they have been assumed to sense exogenous antigens in the airway lumen [38, 39]. In vivo studies using triple cell co-cultures or silicone matrixes have shown that monocyte-derived DCs can internalize corpuscular antigens of 1 μm or larger [40, 41]. However, ex vivo results of both the present study and the investigations of Veres et al. [26] provide evidence that conducting airway epithelial DCs sense corpuscular antigens (E. coli particles, polystyrene beads, or A. fumigatus conidia) without immediate contact. Our data revealed that conducting airway epithelial DCs can occasionally take up conidia, but not in mice that exhibited AAI. This finding may result from an enhanced neutrophil ingestion activity that was observed in conducting airways of challenged OVA mice.

We demonstrated that allergen challenge activated the transepithelial migration, followed by the massive neutrophil recruitment to the airways. Subsequently, on the luminal side of the conducting airway epithelium, neutrophils captured conidia and thereby prevented epithelial DC-conidia contacts. Although epithelial DC-conidial interactions in conducting airways rarely occur, the phenomenon should be investigated further.

In contrast to the epithelial DCs, spherical MHC II+ APCs captured conidia in the subepithelial space. Nevertheless, these APCs had a lower contribution than neutrophils in conidial internalization in both AAI and control mice. Thus, our data indicated that along with alveolar macrophages, conducting airway neutrophils are the primary cells to encounter aspirated A. fumigatus conidia.

In addition, while more than 80% of A. fumigatus conidia were internalized by BAL phagocytes only about 50% of spores were internalized by the joint efforts of conducting airway neutrophils and APCs 24 hours after the application of conidia to both OVA/OVA and OVA/PBS mice. The fungal spores that remained unbound by the main phagocytes can hide in the airway tissue until favorable for germination condition and therefore they can be considered as a life-threating factor.

To summarize, we demonstrated that application of conidia at the acute phase of AAI induces a massive neutrophil influx to conducting airways, bringing the migrated cells into close proximity with the conducting airway epithelium, followed by transmigration to the luminal side. The more than two-fold increase in neutrophil number indicated an intensification of the process of neutrophil-conidial interaction and spore internalization. Surprisingly, when the number of neutrophils in the conducting airways of mice with AAI reduced, the effectiveness of ingestion by these neutrophils remained significantly higher than in control mice. In addition, the increased ability to internalize corpuscular antigens was caused by the activated state rather than by the number of conducting airway neutrophils. In vitro studies have shown that internalization of fungal spores is crucial for conidia killing [17]. On the other hand, internalization of resting conidia and subsequent degradation of the hydrophobic surface layer in phagolysosomes enables their recognition by the intracellular pattern recognition receptors and initiates inflammatory response [9, 42]. Hence, the allergen-induced enhancement of the capacity of conduction airway neutrophils (that we observed in mice with AAI but not in control animals) may indicate a break in tolerance to resting fungal spores that is normally exhibited by immunocompetent hosts [8]. Epidemiologic studies have associated sensitivity to Aspergillus fungi with the severe persistent asthma in adults [2]. Thus, the allergen-induced skewing from tolerance to sensitization can partially explain the potential of inhaled fungal spores to exacerbate asthma symptoms.

Conclusions

In conclusion, our data show that at the acute phase of AAI, neutrophils are sufficient to control resting fungal spore dissemination. We demonstrated that the ingestion potential of neutrophils strongly depends on both the time and the location of the cell-pathogen interaction. Our data suggest that allergen-induced enhancement of the ingestion potential of conduction airway neutrophils may be a reason for the susceptibility of asthmatic patients to Aspergillus infection.

Abbreviations

AAI: 

Allergic airway inflammation

AMM: 

Aspergillus minimal medium

APC: 

Antigen presenting cell

BAL: 

Bronchoalveolar lavage

Cy5: 

Cyanine 5

DC: 

Dendritic cell

FITC: 

Fluorescein isothiocyanate

GPI: 

Glycosylphosphatidylinisotol

i.p: 

Intraperitoneal

MHC: 

Major histocompatibility complex

MIP: 

Maximum intensity projection

OVA: 

Chicken ovalbumin

OVA/OVA mice: 

A group of mice that received intraperitoneal injection of ovalbumin and subsequent aerosol challenges with ovalbumin

OVA/PBS mice: 

A group of mice that received intraperitoneal injection of ovalbumin and subsequent aerosol challenge with PBS

PBS: 

Phosphate buffered saline

TRITC: 

Tetramethylrhodamine-(5-(and-6))-isothiocyanate.

Declarations

Acknowledgements

This work was partially supported by Russian Foundation for Basic Research project No. 11-04-01954a, and by Molecular and Cellular Biology Program of Russian Academy of Sciences in. We also acknowledge the support of the European Respiratory Society, Fellowship number 620. The authors thank Philipp S. Schmalhorst for providing the Aspergillus fumigatus conidia clinical isolate D141. This work was partially carried out at the Department of Airway Immunology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany, and we thank Drs Armin Braun and Tibor Z. Veres for their insightful comments, and Emma Spies for technical assistance.

Authors’ Affiliations

(1)
Department of Immunology, Laboratory of Cell Interactions, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
(2)
Faculty of Postgraduate Education, Pirogov Russian National Research Medical University, Ministry of Health

References

  1. Latge JP: The pathobiology of Aspergillus fumigatus. Trends Microbiol. 2001, 9 (8): 382-389. 10.1016/S0966-842X(01)02104-7.PubMedView ArticleGoogle Scholar
  2. Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, Fairs A, Greenberger PA, Kariuki B, Kita H, Kurup VP, et al: Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol. 2012, 129 (2): 280-291. 10.1016/j.jaci.2011.12.970. quiz 292–283PubMedView ArticleGoogle Scholar
  3. Porter PC, Roberts L, Fields A, Knight M, Qian Y, Delclos GL, Han S, Kheradmand F, Corry DB: Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease. Infect Immun. 2011, 79 (11): 4459-4471. 10.1128/IAI.05209-11.PubMedPubMed CentralView ArticleGoogle Scholar
  4. Fukushima C, Matsuse H, Fukahori S, Tsuchida T, Kawano T, Senjyu H, Kohno S: Aspergillus fumigatus synergistically enhances mite-induced allergic airway inflammation. Med Sci Monit. 2010, 16 (7): BR197-202.PubMedGoogle Scholar
  5. Porter P, Susarla SC, Polikepahad S, Qian Y, Hampton J, Kiss A, Vaidya S, Sur S, Ongeri V, Yang T, et al: Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol. 2009, 2 (6): 504-517. 10.1038/mi.2009.102.PubMedPubMed CentralView ArticleGoogle Scholar
  6. Palm NW, Rosenstein RK, Medzhitov R: Allergic host defences. Nature. 2012, 484 (7395): 465-472. 10.1038/nature11047.PubMedView ArticleGoogle Scholar
  7. Agarwal R, Aggarwal AN, Gupta D, Jindal SK: Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009, 13 (8): 936-944.PubMedGoogle Scholar
  8. Aimanianda V, Bayry J, Bozza S, Kniemeyer O, Perruccio K, Elluru SR, Clavaud C, Paris S, Brakhage AA, Kaveri SV, et al: Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature. 2009, 460 (7259): 1117-1121. 10.1038/nature08264.PubMedView ArticleGoogle Scholar
  9. Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F: Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol. 2007, 9 (2): 368-381. 10.1111/j.1462-5822.2006.00796.x.PubMedView ArticleGoogle Scholar
  10. Bayry J, Aimanianda V, Guijarro JI, Sunde M, Latge JP: Hydrophobins-unique fungal proteins. PLoS Pathog. 2012, 8 (5): e1002700-10.1371/journal.ppat.1002700.PubMedPubMed CentralView ArticleGoogle Scholar
  11. Fukahori S, Matsuse H, Tsuchida T, Kawano T, Tomari S, Fukushima C, Kohno S: Aspergillus fumigatus regulates mite allergen-pulsed dendritic cells in the development of asthma. Clin Exp Allergy. 2010, 40 (10): 1507-1515. 10.1111/j.1365-2222.2010.03520.x.PubMedView ArticleGoogle Scholar
  12. Rivera A, Van Epps HL, Hohl TM, Rizzuto G, Pamer EG: Distinct CD4+−T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect Immun. 2005, 73 (11): 7170-7179. 10.1128/IAI.73.11.7170-7179.2005.PubMedPubMed CentralView ArticleGoogle Scholar
  13. Dougherty RH, Fahy JV: Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy. 2009, 39 (2): 193-202. 10.1111/j.1365-2222.2008.03157.x.PubMedPubMed CentralView ArticleGoogle Scholar
  14. Mircescu MM, Lipuma L, van Rooijen N, Pamer EG, Hohl TM: Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis. 2009, 200 (4): 647-656. 10.1086/600380.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Hasenberg M, Behnsen J, Krappmann S, Brakhage A, Gunzer M: Phagocyte responses towards Aspergillus fumigatus. Int J Med Microbiol. 2011, 301 (5): 436-444. 10.1016/j.ijmm.2011.04.012.PubMedView ArticleGoogle Scholar
  16. Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB: Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia. Infect Immun. 2006, 74 (12): 6528-6539. 10.1128/IAI.00909-06.PubMedPubMed CentralView ArticleGoogle Scholar
  17. Bruns S, Kniemeyer O, Hasenberg M, Aimanianda V, Nietzsche S, Thywissen A, Jeron A, Latge JP, Brakhage AA, Gunzer M: Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog. 2010, 6 (4): e1000873-10.1371/journal.ppat.1000873.PubMedPubMed CentralView ArticleGoogle Scholar
  18. Lommatzsch M, Julius P, Kuepper M, Garn H, Bratke K, Irmscher S, Luttmann W, Renz H, Braun A, Virchow JC: The course of allergen-induced leukocyte infiltration in human and experimental asthma. J Allergy Clin Immunol. 2006, 118 (1): 91-97. 10.1016/j.jaci.2006.02.034.PubMedView ArticleGoogle Scholar
  19. Page K, Lierl KM, Hughes VS, Zhou P, Ledford JR, Wills-Karp M: TLR2-mediated activation of neutrophils in response to German cockroach frass. J Immunol. 2008, 180 (9): 6317-6324.PubMedPubMed CentralView ArticleGoogle Scholar
  20. Baines KJ, Simpson JL, Scott RJ, Gibson PG: Immune responses of airway neutrophils are impaired in asthma. Exp Lung Res. 2009, 35 (7): 554-569. 10.1080/01902140902777490.PubMedView ArticleGoogle Scholar
  21. Reichard U, Buttner S, Eiffert H, Staib F, Ruchel R: Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol. 1990, 33 (4): 243-251. 10.1099/00222615-33-4-243.PubMedView ArticleGoogle Scholar
  22. Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML, Salmen R, Battelli LA, Willard PA, Hoover MD, Hubbs AF: Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A. 2003, 66 (15): 1441-1452.PubMedView ArticleGoogle Scholar
  23. Veres TZ, Shevchenko M, Krasteva G, Spies E, Prenzler F, Rochlitzer S, Tschernig T, Krug N, Kummer W, Braun A: Dendritic cell-nerve clusters are sites of T cell proliferation in allergic airway inflammation. Am J Pathol. 2009, 174 (3): 808-817. 10.2353/ajpath.2009.080800.PubMedPubMed CentralView ArticleGoogle Scholar
  24. von Garnier C, Wikstrom ME, Zosky G, Turner DJ, Sly PD, Smith M, Thomas JA, Judd SR, Strickland DH, Holt PG, et al: Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. J Immunol. 2007, 179 (9): 5748-5759.PubMedView ArticleGoogle Scholar
  25. Veres TZ, Voedisch S, Spies E, Valtonen J, Prenzler F, Braun A: Aeroallergen Challenge Promotes Dendritic Cell Proliferation in the Airways. J Immunol. 2013, 190 (3): 897-903. 10.4049/jimmunol.1200220.PubMedView ArticleGoogle Scholar
  26. Veres TZ, Voedisch S, Spies E, Tschernig T, Braun A: Spatiotemporal and functional behavior of airway dendritic cells visualized by two-photon microscopy. Am J Pathol. 2011, 179 (2): 603-609. 10.1016/j.ajpath.2011.04.039.PubMedView ArticleGoogle Scholar
  27. Gresnigt MS, Joosten LA, Verschueren I, van der Meer JW, Netea MG, Dinarello CA, van de Veerdonk FL: Neutrophil-mediated inhibition of proinflammatory cytokine responses. J Immunol. 2012, 189 (10): 4806-4815. 10.4049/jimmunol.1103551.PubMedView ArticleGoogle Scholar
  28. Bhakta NR, Woodruff PG: Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev. 2011, 242 (1): 220-232. 10.1111/j.1600-065X.2011.01032.x.PubMedPubMed CentralView ArticleGoogle Scholar
  29. Herz U, Braun A, Ruckert R, Renz H: Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy. 1998, 28 (5): 625-634. 10.1046/j.1365-2222.1998.00280.x.PubMedView ArticleGoogle Scholar
  30. Taube C, Dakhama A, Rha YH, Takeda K, Joetham A, Park JW, Balhorn A, Takai T, Poch KR, Nick JA, et al: Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors. J Immunol. 2003, 170 (8): 4301-4309.PubMedView ArticleGoogle Scholar
  31. Delayre-Orthez C, de Blay F, Frossard N, Pons F: Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy. 2004, 34 (11): 1789-1795. 10.1111/j.1365-2222.2004.02082.x.PubMedView ArticleGoogle Scholar
  32. Peters M, Dudziak K, Stiehm M, Bufe A: T-cell polarization depends on concentration of the danger signal used to activate dendritic cells. Immunol Cell Biol. 2010, 88 (5): 537-544. 10.1038/icb.2010.3.PubMedView ArticleGoogle Scholar
  33. Zemans RL, Colgan SP, Downey GP: Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol. 2009, 40 (5): 519-535. 10.1165/rcmb.2008-0348TR.PubMedPubMed CentralView ArticleGoogle Scholar
  34. Latge JP: Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999, 12 (2): 310-350.PubMedPubMed CentralGoogle Scholar
  35. Bozza S, Gaziano R, Spreca A, Bacci A, Montagnoli C, di Francesco P, Romani L: Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol. 2002, 168 (3): 1362-1371.PubMedView ArticleGoogle Scholar
  36. Ibrahim-Granet O, Philippe B, Boleti H, Boisvieux-Ulrich E, Grenet D, Stern M, Latge JP: Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun. 2003, 71 (2): 891-903. 10.1128/IAI.71.2.891-903.2003.PubMedPubMed CentralView ArticleGoogle Scholar
  37. Krenke R, Grabczak EM: Tracheobronchial manifestations of Aspergillus infections. ScientificWorldJournal. 2011, 11: 2310-2329.PubMedPubMed CentralView ArticleGoogle Scholar
  38. Lambrecht BN, Hammad H: Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu Rev Immunol. 2012, 30: 243-270. 10.1146/annurev-immunol-020711-075021.PubMedView ArticleGoogle Scholar
  39. Stumbles PA, Upham JW, Holt PG: Airway dendritic cells: co-ordinators of immunological homeostasis and immunity in the respiratory tract. APMIS. 2003, 111 (7–8): 741-755.PubMedView ArticleGoogle Scholar
  40. Blank F, Rothen-Rutishauser B, Gehr P: Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol. 2007, 36 (6): 669-677. 10.1165/rcmb.2006-0234OC.PubMedView ArticleGoogle Scholar
  41. Behnsen J, Narang P, Hasenberg M, Gunzer F, Bilitewski U, Klippel N, Rohde M, Brock M, Brakhage AA, Gunzer M: Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans. PLoS Pathog. 2007, 3 (2): e13-10.1371/journal.ppat.0030013.PubMedPubMed CentralView ArticleGoogle Scholar
  42. Faro-Trindade I, Willment JA, Kerrigan AM, Redelinghuys P, Hadebe S, Reid DM, Srinivasan N, Wainwright H, Lang DM, Steele C, et al: Characterisation of innate fungal recognition in the lung. PLoS One. 2012, 7 (4): e35675-10.1371/journal.pone.0035675.PubMedPubMed CentralView ArticleGoogle Scholar

Copyright

© Shevchenko et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement